Frontier Capital Management CO LLC Lannett CO Inc Transaction History

Frontier Capital Management CO LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 30, 2018	SELL	$4.75 - $14.5 $4 Million - $12.2 Million	-841,582 Closed	0 $0
Q2 2018 Aug 03, 2018	SELL	$13.3 - $17.45 $1.86 Million - $2.44 Million	-139,783 Reduced 14.24%	841,582 $11.4 Million
Q1 2018 Apr 30, 2018	BUY	$14.7 - $24.95 $887,659 - $1.51 Million	60,385 Added 6.56%	981,365 $15.8 Million
Q4 2017 Jan 18, 2018	BUY	$19.9 - $29.25 $18.3 Million - $26.9 Million	920,980	920,980 $21.4 Million

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Frontier Capital Management CO LLC with notifications on news.